Search

everythinglearnresearchcommunity

for

Search:↓

A patient with "strawberry gingivitis" improved after correct treatment for Granulomatosis with polyangiitis, highlighting the need for early diagnosis.

A Jordanian family with Clouston syndrome has a common GJB6 gene mutation.

The Celsr1 gene is crucial for normal hair patterning in mice.

The mystacial pad's innervation in adult rats is more complex than previously thought.

Hedgehog signaling is crucial for mammary gland development over hair follicles.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Gambogic Amide helps maintain hair color and promotes hair growth.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

The model helps understand how wool fiber structure affects its strength and flexibility.

MRL/MpJ mice's skin wounds heal with scars, unlike their ear wounds which can regenerate.

CDP is crucial for lung and hair follicle cell development.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

NEDD4 and NEDD4L help control intestinal stem cells and prevent tumors by breaking down the LGR5 receptor.

Tideglusib with a bacterial cellulose hydrogel improves wound healing in rats.

The Naked (N) trait in mice is linked to lower glycine and tyrosine in hair proteins.

Cedrol promotes hair growth better than baricitinib by regulating immune cells.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

GLABRA2 gene controls root-hair growth by regulating phospholipid signaling.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Reducing PIEZO1 speeds up wound healing.

JAK inhibitors are effective for long-term management of alopecia areata.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

I cannot summarize the document because it cannot be parsed.

Ruxolitinib helped a patient with alopecia areata regrow hair.